• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA在结直肠癌发生、诊断、预后及治疗中的意义

Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics.

作者信息

Zhai Haiyan, Ju Jingfang

机构信息

Translational Research Laboratory, Department of Pathology, State University of New York at Stony Brook, Stony Brook, NY, USA.

出版信息

Front Genet. 2011 Nov 3;2(78). doi: 10.3389/fgene.2011.00078.

DOI:10.3389/fgene.2011.00078
PMID:22114584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3221387/
Abstract

MicroRNAs (miRNAs) are a class of non-coding small RNAs with critical regulatory functions as post-transcriptional regulators. Due to the fundamental importance and broad impact of miRNAs on multiple genes and pathways, dysregulated miRNAs have been associated with human diseases, including cancer. Colorectal cancer (CRC) is among the most deadly diseases, and miRNAs offer a new frontier for target discovery and novel biomarkers for both diagnosis and prognosis. In this review, we summarize the recent advancement of miRNA research in CRC, in particular, the roles of miRNAs in CRC stem cells, epithelial-to-mesenchymal transition, chemoresistance, therapeutics, diagnosis, and prognosis.

摘要

微小RNA(miRNA)是一类非编码小RNA,作为转录后调节因子具有关键的调节功能。由于miRNA对多个基因和通路具有根本重要性和广泛影响,其失调与包括癌症在内的人类疾病相关。结直肠癌(CRC)是最致命的疾病之一,而miRNA为靶点发现以及用于诊断和预后的新型生物标志物提供了新的领域。在本综述中,我们总结了CRC中miRNA研究的最新进展,特别是miRNA在CRC干细胞、上皮-间质转化、化疗耐药性、治疗、诊断和预后中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/083d/3268631/688039d9cb04/fgene-02-00078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/083d/3268631/688039d9cb04/fgene-02-00078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/083d/3268631/688039d9cb04/fgene-02-00078-g001.jpg

相似文献

1
Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics.微小RNA在结直肠癌发生、诊断、预后及治疗中的意义
Front Genet. 2011 Nov 3;2(78). doi: 10.3389/fgene.2011.00078.
2
Roles of miRNA in the initiation and development of colorectal carcinoma.微小RNA在结直肠癌发生发展中的作用。
Curr Pharm Des. 2012 Sep 25.
3
Roles of miRNA in the initiation and development of colorectal carcinoma.miRNA 在结直肠癌发生和发展中的作用。
Curr Pharm Des. 2013;19(7):1253-61. doi: 10.2174/138161213804805784.
4
Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance.微小 RNA 在结直肠癌中的分子功能:在增殖、血管生成、凋亡和化疗耐药性中的最新作用。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5617-5630. doi: 10.1007/s00210-024-03076-w. Epub 2024 Apr 15.
5
The Dual Role of MicroRNAs in Colorectal Cancer Progression.microRNAs 在结直肠癌进展中的双重作用
Int J Mol Sci. 2018 Sep 17;19(9):2791. doi: 10.3390/ijms19092791.
6
MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.微小RNA作为治疗靶点与结直肠癌治疗
Adv Exp Med Biol. 2016;937:239-47. doi: 10.1007/978-3-319-42059-2_13.
7
The significance of exosomal non-coding RNAs (ncRNAs) in the metastasis of colorectal cancer and development of therapy resistance.外泌体非编码RNA(ncRNAs)在结直肠癌转移和治疗耐药性发展中的意义。
Gene. 2025 Feb 10;937:149141. doi: 10.1016/j.gene.2024.149141. Epub 2024 Dec 4.
8
[The Role of MicroRNAs in Colorectal Cancer].[微小RNA在结直肠癌中的作用]
Korean J Gastroenterol. 2017 Apr 25;69(4):206-211. doi: 10.4166/kjg.2017.69.4.206.
9
Biomarkers for Stratification in Colorectal Cancer: MicroRNAs.结直肠癌分层的生物标志物:microRNAs。
Cancer Control. 2019 Jan-Dec;26(1):1073274819862784. doi: 10.1177/1073274819862784.
10
Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.用于结直肠癌诊断和预后的新兴 microRNA 生物标志物。
Open Biol. 2019 Jan 31;9(1):180212. doi: 10.1098/rsob.180212.

引用本文的文献

1
Exosome-Mediated miR-21 Was Involved in the Promotion of Structural and Functional Recovery Effect Produced by Electroacupuncture in Sciatic Nerve Injury.外泌体介导的 miR-21 参与电针对坐骨神经损伤的结构和功能恢复作用的促进。
Oxid Med Cell Longev. 2022 Jan 29;2022:7530102. doi: 10.1155/2022/7530102. eCollection 2022.
2
miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1.微小RNA-330通过靶向BACH1调控结直肠癌的发生。
Adv Pharm Bull. 2020 Jul;10(3):444-451. doi: 10.34172/apb.2020.054. Epub 2020 May 11.
3
miR-381 Mediates the Development of Head and Neck Squamous Cell Carcinoma via Targeting STC2.

本文引用的文献

1
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.微小 RNA-194 通过靶向癌基因 BMI-1 抑制子宫内膜癌细胞的上皮间质转化。
Mol Cancer. 2011 Aug 18;10:99. doi: 10.1186/1476-4598-10-99.
2
Prognostic significance of miR-215 in colon cancer.miR-215 在结肠癌中的预后意义。
Clin Colorectal Cancer. 2011 Dec;10(4):340-7. doi: 10.1016/j.clcc.2011.06.002. Epub 2011 Jul 12.
3
Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
微小RNA-381通过靶向STC2介导头颈部鳞状细胞癌的发展。
Onco Targets Ther. 2020 May 21;13:4485-4493. doi: 10.2147/OTT.S246289. eCollection 2020.
4
Clinicopathological and Prognostic Characteristics of RAD51 in Colorectal Cancer.结直肠癌中RAD51的临床病理及预后特征
Medicina (Kaunas). 2020 Jan 21;56(2):48. doi: 10.3390/medicina56020048.
5
Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs.基于微小RNA的结直肠癌原发肿瘤的新型分子特征分析
Cancers (Basel). 2019 Mar 11;11(3):346. doi: 10.3390/cancers11030346.
6
Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells.开发具有增强疗效的新型miR-129模拟物以消除化疗耐药的结肠癌干细胞。
Oncotarget. 2017 Nov 6;9(10):8887-8897. doi: 10.18632/oncotarget.22322. eCollection 2018 Feb 6.
7
miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells.miR-133b 通过靶向 GSTP1 逆转顺铂耐药肺癌细胞中的顺铂耐药性。
Int J Mol Med. 2018 Apr;41(4):2050-2058. doi: 10.3892/ijmm.2018.3382. Epub 2018 Jan 11.
8
Expression analysis of microRNA as prognostic biomarkers in colorectal cancer.作为结直肠癌预后生物标志物的微小RNA表达分析
Oncotarget. 2016 Dec 26;8(32):52403-52412. doi: 10.18632/oncotarget.14175. eCollection 2017 Aug 8.
9
miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma.miR-503-5p通过靶向puma赋予结直肠癌耐药性。
Oncotarget. 2017 Mar 28;8(13):21719-21732. doi: 10.18632/oncotarget.15559.
10
miR-659-3p is involved in the regulation of the chemotherapy response of colorectal cancer via modulating the expression of SPHK1.微小RNA-659-3p通过调节鞘氨醇激酶1的表达参与结直肠癌化疗反应的调控。
Am J Cancer Res. 2016 Sep 1;6(9):1976-1985. eCollection 2016.
全基因组范围内组蛋白特征分析揭示了结直肠癌中 microRNA 基因的表观遗传调控。
Cancer Res. 2011 Sep 1;71(17):5646-58. doi: 10.1158/0008-5472.CAN-11-1076. Epub 2011 Jul 6.
4
MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.miR-145 和 miR-33a 的微小 RNA 替代疗法在结肠癌模型中有效。
Cancer Res. 2011 Aug 1;71(15):5214-24. doi: 10.1158/0008-5472.CAN-10-4645. Epub 2011 Jun 20.
5
Isolation and characterization of spheroid cells from the HT29 colon cancer cell line.从 HT29 结肠癌细胞系中分离和鉴定球体细胞。
Int J Colorectal Dis. 2011 Oct;26(10):1279-85. doi: 10.1007/s00384-011-1248-y. Epub 2011 Jun 14.
6
LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms.LIN28B 通过 let-7 依赖和非依赖机制促进结直肠癌迁移、侵袭和转化。
Oncogene. 2011 Oct 6;30(40):4185-93. doi: 10.1038/onc.2011.131. Epub 2011 May 30.
7
Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells.miR-22 的过表达通过激活 p53 突变型结肠癌细胞中的 PTEN 信号转导逆转紫杉醇诱导的化疗耐药性。
Mol Cell Biochem. 2011 Nov;357(1-2):31-8. doi: 10.1007/s11010-011-0872-8. Epub 2011 May 19.
8
Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer.慢性炎症或遗传(APC(Min/+))结肠癌模型肿瘤中 microRNAs 的差异表达。
PLoS One. 2011 Apr 12;6(4):e18501. doi: 10.1371/journal.pone.0018501.
9
LIN28B promotes colon cancer progression and metastasis.LIN28B 促进结肠癌的进展和转移。
Cancer Res. 2011 Jun 15;71(12):4260-8. doi: 10.1158/0008-5472.CAN-10-4637. Epub 2011 Apr 21.
10
Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis.循环血浆 miR-141 是转移性结直肠癌的新型生物标志物,可预测不良预后。
PLoS One. 2011 Mar 17;6(3):e17745. doi: 10.1371/journal.pone.0017745.